These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 22432998)

  • 1. Efficacy of rituximab in refractory antisynthetase syndrome.
    Limaye V; Hissaria P; Liew CL; Koszyka B
    Intern Med J; 2012 Mar; 42(3):e4-7. PubMed ID: 22432998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is tacrolimus effective for treating antisynthetase-associated interstitial lung disease?
    Bongartz T; Ryu JH; Matteson EL
    Nat Clin Pract Rheumatol; 2005 Dec; 1(2):80-1. PubMed ID: 16932636
    [No Abstract]   [Full Text] [Related]  

  • 3. Rituximab in the Treatment of Jo1 Antibody-associated Antisynthetase Syndrome: Anti-Ro52 Positivity as a Marker for Severity and Treatment Response.
    Bauhammer J; Blank N; Max R; Lorenz HM; Wagner U; Krause D; Fiehn C
    J Rheumatol; 2016 Aug; 43(8):1566-74. PubMed ID: 27252419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-melanoma differentiation-associated protein 5-associated dermatomyositis: expanding the clinical spectrum.
    Hall JC; Casciola-Rosen L; Samedy LA; Werner J; Owoyemi K; Danoff SK; Christopher-Stine L
    Arthritis Care Res (Hoboken); 2013 Aug; 65(8):1307-15. PubMed ID: 23436757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful multi-target therapy including rituximab and mycophenolate mofetil in anti-melanoma differentiation-associated gene 5 antibody-positive rapidly progressive interstitial lung disease with clinically amyopathic dermatomyositis.
    Hisanaga J; Kotani T; Fujiki Y; Yoshida S; Takeuchi T; Makino S
    Int J Rheum Dis; 2017 Dec; 20(12):2182-2185. PubMed ID: 28752606
    [No Abstract]   [Full Text] [Related]  

  • 6. Jo1-antisynthetase syndrome and severe interstitial lung disease with organising pneumonia on histopathology with favourable outcome on early combined treatment with corticosteroids, mycophenolate mofetil and rituximab.
    Rüegg CA; Maurer B; Laube I; Scholtze D
    BMJ Case Rep; 2019 Sep; 12(9):. PubMed ID: 31519721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Juvenile dermatomyositis: immunopathogenesis, role of myositis-specific autoantibodies, and review of rituximab use.
    Chiu YE; Co DO
    Pediatr Dermatol; 2011; 28(4):357-67. PubMed ID: 21793879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rituximab in refractory idiopathic inflammatory myopathies and antisynthetase syndrome: personal experience and review of the literature.
    Nalotto L; Iaccarino L; Zen M; Gatto M; Borella E; Domenighetti M; Punzi L; Doria A
    Immunol Res; 2013 Jul; 56(2-3):362-70. PubMed ID: 23572427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dermatomyositis with Rapidly Progressive Interstitial Lung Disease Treated with Rituximab: A Report of 3 Cases in Japan.
    Tokunaga K; Hagino N
    Intern Med; 2017; 56(11):1399-1403. PubMed ID: 28566605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rituximab in the treatment of antisynthetase syndrome.
    Brulhart L; Waldburger JM; Gabay C
    Ann Rheum Dis; 2006 Jul; 65(7):974-5. PubMed ID: 16769789
    [No Abstract]   [Full Text] [Related]  

  • 11. Antisynthetase syndrome.
    Katzap E; Barilla-LaBarca ML; Marder G
    Curr Rheumatol Rep; 2011 Jun; 13(3):175-81. PubMed ID: 21455765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of antisynthetase syndrome in patients with idiopathic interstitial pneumonias.
    Watanabe K; Handa T; Tanizawa K; Hosono Y; Taguchi Y; Noma S; Kobashi Y; Kubo T; Aihara K; Chin K; Nagai S; Mimori T; Mishima M
    Respir Med; 2011 Aug; 105(8):1238-47. PubMed ID: 21514811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab therapy for refractory interstitial lung disease related to antisynthetase syndrome.
    Marie I; Dominique S; Janvresse A; Levesque H; Menard JF
    Respir Med; 2012 Apr; 106(4):581-7. PubMed ID: 22280877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dermatomyositis and acute interstitial lung disease associated with MDA-5 antibodies: an atypical case].
    Girard C; Vincent T; Bessis D
    Ann Dermatol Venereol; 2013 Oct; 140(10):628-34. PubMed ID: 24090894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interstitial lung disease in a patient with antisynthetase syndrome and no myositis.
    Plastiras SC; Soliotis FC; Vlachoyiannopoulos P; Tzelepis GE
    Clin Rheumatol; 2007 Jan; 26(1):108-11. PubMed ID: 16328094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interstitial lung disease and inflammatory myopathy in antisynthetase syndrome with PL-12 antibody.
    Jubber A; Tripathi M; Taylor J
    BMJ Case Rep; 2018 Oct; 2018():. PubMed ID: 30323103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tocilizumab for refractory rapidly progressive interstitial lung disease related to anti-MDA5-positive dermatomyositis.
    Zhang X; Zhou S; Wu C; Li M; Wang Q; Zhao Y; Zeng X
    Rheumatology (Oxford); 2021 Jul; 60(7):e227-e228. PubMed ID: 33410494
    [No Abstract]   [Full Text] [Related]  

  • 18. [Evaluation of the effectiveness of treatment with rituximab associated to cyclophosphamide in patients with resistant idiopathic inflammatory myopathy].
    García Hernández FJ; Chinchilla Palomares E; Castillo Palma MJ; González Pulido C; Ocaña Medina C; Sánchez Román J
    Med Clin (Barc); 2010 Jul; 135(6):256-9. PubMed ID: 20537666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reaction of anti-OJ autoantibodies with components of the multi-enzyme complex of aminoacyl-tRNA synthetases in addition to isoleucyl-tRNA synthetase.
    Targoff IN; Trieu EP; Miller FW
    J Clin Invest; 1993 Jun; 91(6):2556-64. PubMed ID: 8514867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dramatic improvement after rituximab in a patient with paraneoplastic treatment-refractory Morvan syndrome associated with anti-CASPR2 antibodies.
    Ong E; Viaccoz A; Ducray F; Pérol M; Cavillon G; Rogemond V; Honnorat J; Petiot P
    Eur J Neurol; 2013 Jul; 20(7):e96-7. PubMed ID: 23750840
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.